Home › Metabolic Disorders › Tennessee
Metabolic Disorders clinical trials in Tennessee
4 studies for Metabolic Disorders are looking for participants at sites in Tennessee.
Cities in Tennessee
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06525636A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chattanooga
- 89bio Clinical Study Site, Cordova
- 89bio Clinical Study Site, Hermitage
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Cordova
- 89bio Clinical Study Site, Hermitage
- 89bio Clinical Study Site, Nashville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374Rare and Atypical Diabetes Network
- Vanderbilt University, Nashville
RecruitingObservational study
All ages · All sexes · Updated Aug 14, 2025 · NCT05544266From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.